Germany Molecular Diagnostic Market for 38 NA Tests Assessed in New Report Available at

12 Jun 2012 • by Natalie Aster

LONDON – Resistance development often represents the major cause of treatment failure and is a clinical problem in a number of microorganisms. Traditional methods for resistance determination may within a few years be replaced by nucleic acid (NA) tests. The most commonly used NA tests available today are however not used in the clinical laboratory on a daily routine work basis. As fabrication costs reduce and validated targeted assays are developed, it is most likely that NA tests will become important alternatives outside the research laboratories for determination of antimicrobial resistance.

New market research report “Assessment of the Molecular Diagnostic Market for 38 NA Tests in Germany, 2011” worked out by data information intelligence GmbH provides in-depth evaluation of Germany’s molecular diagnostic market for 38 NA tests. Its scope comprises:
total number of clinical diagnostic labs by segment;
number of clinical diagnostic NA labs by segment;
number of lab performing test by test types;
total number of test/results per test type & growth rate;
market shares – for amplification & detection platforms and reagents be test type;
major trends.

Report Details:

Assessment of the Molecular Diagnostic Market for 38 NA Tests in Germany, 2011
Published: May, 2012
Price: US$ 9.000,00

Reports on Other Countries Molecular Diagnostic Markets for 38 NA Tests are Also Available:

More new research reports by the publisher can be found at data information intelligence GmbH page.


MarketPublishers, Ltd.
Tanya Rezler
Tel: +44 208 144 6009
Fax: +44 207 900 3970